Abstract
Background: Lymphoseek is a radiopharmaceutical designed for sentinel lymph node (SLN) mapping. The purpose of this study was to compare Lymphoseek colon and gastric pharmacokinetics with filtered [99mTc]sulfur colloid (fTcSC).
Methods: Eight anesthetized pigs received an endoscopic injection of Lymphoseek or fTcSC in the stomach and colon. Scintigraphy was obtained of both administration sites at 15-minute intervals up to 3 hours after injection, after which all SLNs were identified by a handheld gamma probe through a laparotomy incision. Isosulfan blue was administered at the injection site 5 minutes before SLN mapping. The percentage of injected dose (%ID) was measured for all harvested nodes, and the clearance half-life (T c) was calculated for all injection sites.
Results: The mean Lymphoseek clearance for colon (T c, 2.56 ± 1.04 hours) and gastric (T c, 3.83 ± 1.18 hours) injection sites was statistically faster (P = .030) compared with fTcSC (colon T c, 14.98 ± 3.41 hours; stomach T c, 14.52 ± 4.08 hours). After 3 hours, Lymphoseek exhibited a mean SLN %ID of 1.32% ± 1.71% in the colon and 2.04% ± 2.12% in the stomach; this was not statistically different from fTcSC (colon, .63% ± .39%; stomach, 2.35% ± 2.90%). SLN uptake of Lymphoseek was significantly different from second-echelon node %ID for the colon (P = .011) and gastric (P = .029) injection sites. All SLNs exceeded 10 times background, and there was no discordance between isosulfan blue and Lymphoseek or fTcSC.
Conclusions: Three hours after colon stomach administration, Lymphoseek demonstrated rapid injection site clearance, detectable SLN uptake, and low second-echelon node uptake.
Similar content being viewed by others
REFERENCES
Jemal A, Thomas A, Murray T, Thun M. Cancer statistics 2002. CA Cancer J Clin 2002;52:23–47.
Maruyama K, Gunven P, Okbayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. Ann Surg 1989;210:596–602.
Gervasoni JEJ, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am 2000;80:1631–74.
Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.
Saha S, Nora D, Wong JA, Weise D. Sentinel lymph node mapping in colorectal cancer—a review. Surg Clin North Am 2000;80:1811–20.
Kitagawa Y, Kubota K, Nobutoshi A, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000;80:1799–1810.
Esser S, Reilly T, Riley LB, Eyvazzadeh C, Arcona S. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001;44:850–6.
Paramo JC, Summerall J, Wilson C, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001;182:40–3.
Aikou T, Higashi H, Natsugoe S, Hokita S, Baba M, Tako S. Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Ann Surg Oncol 2001;8:90S–93S.
Tsioulias GJ, Wood T, Spirit M, Morton DL, Bilchik AJ. A novel lymphatic mapping technique to improve localization and staging of early colon cancer during laparoscopic colectomy. Am Surg 2002;68:561–5.
Wood TF, Tsioulias GJ, Morton DL, et al. Focused examination of sentinel lymph upstages early colorectal carcinoma. Am Surg 2000;66:998–1003.
Wiese D, Saha S, Badin J, et al. Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. Arch Pathol Lab Med 2000;124:1759–63.
Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001;19:1128–36.
Hiratsuka M, Miyashiro I, Ishikawa O, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery 2001;129:335–40.
Saha S, Bilchik AJ, Wiese D, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique—a multicenter trial. Ann Surg Oncol 2001;8:94S–98S.
Wood TF, Hora DT, Morton DL, et al. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases. J Gastrointest Surg 2002;6:322–30.
Bilchik AJ, Saha S, Tsioulias GJ, Wood TF, Morton DL. Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms. Ann Surg Oncol 2001;8:82S–85S.
Vera DR, Wallace AM, Hoh CK, Mattrey RF. A synthetic macromolecule for sentinel node detection: [99mTc]DTPA-mannosyl-dextran. J Nucl Med 2001;42:951–9.
Wallace AM, Hoh CK, Vera DR, Darrah D, Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol 2003;10:531–8.
Méndez J, Wallace AM, Hoh CK, Vera DR. Detection of gastric and colonic sentinel nodes via endoscopic administration of Lymphoseek in pigs. J Nucl Med 2003;44:1677–81.
Hoh CK, Wallace AM, Vera DR. Preclinical studies of [99mTc]DPTA-mannosyl-dextran. Nucl Med Biol 2003;30:457–64.
Cohen J. A coefficient of agreement for nominal scales. Educ Prob Pyschol Meas 1960;20:37–46.
Trocha SD, Nora DT, Saha SS, Morton DL, Wiese D, Bilchik AJ. Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J Gastrointest Surg 2003;7:340–6.
Kitagawa Y, Kitajima M. Gastrointestinal cancer and sentinel node navigation surgery. J Surg Oncol 2002;79:188–93.
Kitagawa Y, Watanabe M, Hasegawa H, et al. Sentinel node mapping for colorectal cancer using radioactive tracer. Dis Colon Rectum 2002;45:1476–80.
Kitagawa Y, Ohgami M, Fujii H, et al. Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann Surg Oncol 2001;8:86S–89S.
Hayashi H, Ochiai T, Mori M, et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg 2003;196:68–74.
Ellner SJ, Hoh CK, Vera DR, Darrah DD, Schulteis G, Wallace AM. Dose-dependent biodistribution of [99mTc]DTPA-mannosyl-dextran for breast cancer sentinel node mapping. Nucl Med Biol 2003;30:805–10.
JA Sorenson ME Phelps (Eds) (1987) Physics in Nuclear Medicine EditionNumber2nd ed. Grune & Stratton Orlando, FL
Cserni G, Vajda K, Tarjan M, Bori R, Svebis M, Baltas B. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999;5:291–6.
Joosten J, Strobbe LJ, Wauters CA, Pruszczynski M, Woobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Cancer 1999;86:482–6.
Mulsow J, Winter DC, O’Keane JC, O’Connell PR. Sentinel lymph node mapping in colorectal cancer. Br J Surg 2003;90:659–67.
Wood TF, Saha S, Morton DL, et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001;8:150–7.
Wood TF, Spirt M, Rangel D, et al. Lymphatic mapping improves staging during laparoscopic colectomy for cancer. Surg Endosc 2001;15:715–9.
Guiliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401.
Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335–9.
Albertini J, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy and lymphatic mapping of patients with breast cancer. JAMA 1996;276:1818–22.
McMasters KM, Tuttle T, Carlson D, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560–6.
Hansen NM, Giuliano AE. Lymphatic mapping in breast cancer Nieweg OE, Essner R, Reintgen DS, Thompson JF Eds. Lymphatic Mapping and Probe Applications in Oncology. New York: Marcel Dekker, 2000: 167–83.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ellner, S.J., Méndez, J., Vera, D.R. et al. Sentinel Lymph Node Mapping of the Colon and Stomach Using Lymphoseek in a Pig Model. Ann Surg Oncol 11, 674–681 (2004). https://doi.org/10.1245/ASO.2004.06.007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2004.06.007